PKM2 as a biomarker for chemosensitivity to front-line platinum-based chemotherapy in patients with metastatic non-small-cell lung cancer

BACKGROUND: Tumour cells exclusively express the embryonic M2 isoform of pyruvate kinase (PKM2). PKM2 expression levels have been correlated with the effect of platinum compounds in cancer cell lines and xenograft models. The potential predictive role of PKM2 in patients with metastatic/advanced non...

Descripción completa

Detalles Bibliográficos
Autores principales: Papadaki, C, Sfakianaki, M, Lagoudaki, E, Giagkas, G, Ioannidis, G, Trypaki, M, Tsakalaki, E, Voutsina, A, Koutsopoulos, A, Mavroudis, D, Georgoulias, V, Souglakos, J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4453739/
https://www.ncbi.nlm.nih.gov/pubmed/25233397
http://dx.doi.org/10.1038/bjc.2014.492

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4453739/
https://www.ncbi.nlm.nih.gov/pubmed/25233397
http://dx.doi.org/10.1038/bjc.2014.492

Ejemplares similares